Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-22

Clinical Trial Update: Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture [NA]

View source ↗

Summary

This clinical trial update indicates that the study evaluating bimodal analgesia for pain control after long-bone fractures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Tibia Fracture, Femur Fracture | NA | Status: WITHDRAWN